查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1683389

全球智慧型助听器与语音辨识技术市场 - 2025 至 2033 年

Global Smart Hearing Aids with Speech Recognition Technology Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 215 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球带有语音辨识技术的智慧助听器市场规模达到 78.7 亿美元，预计到 2033 年将达到 308.3 亿美元，在 2025-2033 年预测期内的复合年增长率为 14.6%。

智慧型助听器是一种先进的设备，可以改善听力障碍者的生活品质。它们利用无线连接和人工智慧来适应不同的聆听环境，降低背景噪音，并提高语音清晰度。用户可以透过将多个数位助听器连接到智慧型手机来调整设定、传输音讯并接收即时语言翻译。一些型号还具有健康追踪功能，可以检测事故并监测脉搏率。智慧型助听器透过提供个人化的声音体验来增强沟通、社交参与和独立性。

市场动态：

驱动因素与约束因素

人工智慧和语音辨识的进步

智慧助听器中人工智慧和语音辨识技术的融合正在推动市场成长。这些人工智慧辅助设备可以适应不同的聆听环境，过滤背景噪音，并即时提高语音清晰度。语音命令、自动音量调节和基于机器学习的声音个性化等功能吸引了用户，尤其是那些轻度至重度听力损失的用户。

人工智慧演算法和深度学习模型的不断发展有望进一步增强其能力。例如，2025 年 2 月，助听器创新领域的全球领导者 GN 推出了全球最小的 AI 助听器 ReSound Vivia 和具有蓝牙 LE 音讯和 Auracast 广播音讯功能的必备系列 ReSound Savi。这些助听器在嘈杂的环境中提供卓越的音质和舒适度，同时保持尺寸和电池寿命。 GN 的 AI 模型专注于自然声音处理能力。

高级助听器价格昂贵

全球智慧助听器市场面临挑战，因为先进设备（尤其是整合人工智慧和语音辨识技术的设备）的成本很高。这使得这些设备不太容易获得，特别是对于老年人和保险覆盖范围有限的发展中地区的人来说。例如，一套助听器的价格从 1,000 美元到 3,500 美元不等，一对助听器四年内每天的费用约为 5.57 美元，相当于一杯拿铁的价格。

此外，维护成本、电池更换和有限的报销政策进一步阻碍了这些先进助听器的广泛应用。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 人工智慧和语音辨识的进步
      • 听力障碍盛行率上升
    • 限制
      • 高级助听器价格昂贵
      • 严格的监管要求
    • 机会
      • 拓展新兴市场
    • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 管道分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：依产品类型

  • 耳背式 (BTE)
  • 耳内接收器 (RITE)
  • 耳内式 (ITE)
  • 耳道内 (ITC)
  • 其他的

第 7 章：依听力损失类型

  • 神经性听损失
  • 传导性听力损失
  • 混合性听力损失

第 8 章：按技术

  • 数位的
  • 模拟

第 9 章：依病患组别

  • 成人
  • 儿科

第 10 章：按配销通路

  • 医院
  • 门诊手术中心 (ASC)
  • 家庭护理设置

第 11 章：按地区

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • Sonova
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Starkey Hearing Technologies
  • GN Hearing A/S
  • Demant
  • Eargo
  • Ambiq
  • WS Audiology A/S
  • Similar data will be provided for each market player.
  • 艾尔戈
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • 橄榄联盟
  • 歌词听力
  • 将为每个市场参与者提供类似的资料。

第 14 章：附录

简介目录
Product Code: MD9337

The global smart hearing aids with speech recognition technology market reached US$ 7.87 billion in 2024 and is expected to reach US$ 30.83 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.

Smart hearing aids are advanced devices that improve the quality of life for individuals with hearing loss. They use wireless connectivity and artificial intelligence to adapt to different listening environments, reduce background noise, and enhance speech clarity. Users can adjust settings, stream audio, and receive real-time language translation by connecting multiple digital hearing aids to smartphones. Some models also have health-tracking capabilities, detecting accidents and monitoring pulse rate. Smart hearing aids enhance communication, social engagement, and independence by providing personalized sound experiences.

Market Dynamics: Drivers & Restraints

Advancements in Artificial Intelligence and Speech Recognition

The integration of AI and speech recognition technology in smart hearing aids is driving market growth. These AI-powered aids can adapt to different listening environments, filter background noise, and enhance speech clarity in real-time. Features like voice commands, automatic volume adjustments, and machine learning-based sound personalization attract users, particularly those with mild to severe hearing loss.

The continuous development of AI algorithms and deep learning models is expected to further enhance their capabilities. For instance, in February 2025, GN, the global leader in hearing aid innovation, launched the ReSound Vivia, the world's smallest AI-powered hearing aid, and the ReSound Savi, an essentials range featuring Bluetooth LE Audio and Auracast broadcast audio. These hearing aids offer superior sound quality and comfort in noisy environments while maintaining size and battery life. GN's AI model focuses on natural sound processing capabilities.

High Cost of Advanced Hearing Aids

The global smart hearing aids market faces challenges due to the high costs associated with advanced devices, particularly AI-integrated ones with speech recognition technology. This makes these devices less accessible, especially for elderly individuals and those in developing regions with limited insurance coverage and insurance coverage. For instance, The cost of one hearing aid can range from $1,000 to $3,500, with a pair of hearing aids costing about $5.57 per day over four years, equivalent to the cost of a latte.

Additionally, maintenance costs, battery replacements, and limited reimbursement policies further hinder the widespread adoption of these advanced hearing aids.

Segment Analysis

The global smart hearing aids with speech recognition technology market is segmented based on product type, hearing loss type, technology, patient group, distribution channel, and region.

Product Type:

Behind-the-Ear (BTE) segment in the product type is expected to dominate the smart hearing aids with speech recognition technology market

Behind-the-ear (BTE) hearing aids are a key segment in the global smart hearing aids with speech recognition technology market due to their advanced features, comfort, and adaptability. They use advanced speech recognition technology to enhance speech clarity, filter background noise, and improve voice detection in noisy environments. Their wireless connectivity allows seamless integration with smartphones and other smart devices, making them popular among tech-savvy users. The growing prevalence of age-related hearing loss and demand for AI-powered hearing solutions further fuel the market expansion of BTE smart hearing aids.

Additionally, market players are introducing advanced hearing aids. For instance, in October 2024, ELEHEAR launched its latest innovation, ELEHEAR Beyond Hearing Aids, which uses advanced AI technology to enhance sound clarity, provide customizable tinnitus relief, and offer seamless Bluetooth streaming. These hearing aids are priced at an affordable price, making premium hearing aid technology accessible to the masses without compromising quality.

Geographical Analysis

North America is expected to hold a significant position in the smart hearing aids with speech recognition technology market

North America is a significant contributor to the global smart hearing aids with speech recognition technology market, as evidenced by the rapid adoption of advanced healthcare technologies, the increase in the prevalence of hearing impairment, and the geriatric population. For instance, according to WHO, moreover, 5% of the world's population, or 430 million individuals, need rehabilitation for their debilitating hearing loss. It is anticipated that by 2050, approximately 700 million individuals, or one out of every ten, will have debilitating hearing loss. Disabling hearing loss is defined as hearing loss of more than 35 decibels (dB) in the better-hearing ear.

Moreover, strong R&D investments in the region have resulted in ongoing advancements in AI-powered speech recognition and wireless connectivity in hearing aids also significant factors that help the region to grow during the forecast period.

Competitive Landscape

The major global players in the smart hearing aids with speech recognition technology market include Sonova, Starkey Hearing Technologies, GN Hearing A/S, Demant, Eargo, Ambiq, and WS Audiology A/S among others.

Key Developments

  • In February 2025, Beltone introduced its latest innovation, Beltone Envision hearing aids, which offer the world's best technology for noise management and voice clarity. These aids keep users connected to their surroundings and bring important sounds into clear focus, enhancing their listening experience.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

The global smart hearing aids with speech recognition technology market report delivers a detailed analysis with 69 key tables, more than 70 visually impactful figures, and 215 pages of expert insights, providing a complete view of the market landscape.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Hearing Loss Type
  • 3.3. Snippet by Technology
  • 3.4. Snippet by Patient Group
  • 3.5. Snippet by Distribution Channel
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advancements in Artificial Intelligence and Speech Recognition
      • 4.1.1.2. Rise in the Prevalence of Hearing Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Advanced Hearing Aids
      • 4.1.2.2. Stringent Regulatory Requirements
    • 4.1.3. Opportunity
      • 4.1.3.1. Expansion into Emerging Markets
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Pipeline Analysis
  • 5.8. Supply Chain Analysis
  • 5.9. Patent Analysis
  • 5.10. SWOT Analysis
  • 5.11. Unmet Needs and Gaps
  • 5.12. Recommended Strategies for Market Entry and Expansion
  • 5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.14. Pricing Analysis and Price Dynamics
  • 5.15. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Behind-the-Ear (BTE)*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Receiver-in-the-Ear (RITE)
  • 6.4. In-the-Ear (ITE)
  • 6.5. In-the-Canal (ITC)
  • 6.6. Others

7. By Hearing Loss Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 7.1.2. Market Attractiveness Index, By Hearing Loss Type
  • 7.2. Sensorineural Hearing Loss*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Conductive Hearing Loss
  • 7.4. Mixed Hearing Loss

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Digital*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Analog

9. By Patient Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 9.1.2. Market Attractiveness Index, By Patient Group
  • 9.2. Adult*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Pediatric

10. By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2. Market Attractiveness Index, By Distribution Channel
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgical Centers (ASCs)
  • 10.4. Home Care Settings

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. Latin America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Mexico
      • 11.4.8.2. Brazil
      • 11.4.8.3. Argentina
      • 11.4.8.4. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

Key Market Players

  • 13.1. Sonova*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Starkey Hearing Technologies
  • 13.3. GN Hearing A/S
  • 13.4. Demant
  • 13.5. Eargo
  • 13.6. Ambiq
  • 13.7. WS Audiology A/S
  • Similar data will be provided for each market player.

Emerging Market Players

  • 13.8. Eargo*
    • 13.8.1. Pipeline Products Description
    • 13.8.2. Product Key Performance Indicators (KPIs)
    • 13.8.3. Key Activities
    • 13.8.4. Market Entry Timelines
    • 13.8.5. Product Penetration Rate
    • 13.8.6. Sales Estimation and Projections
  • 13.9. Olive Union
  • 13.10. Lyric Hearing
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us